DFX Intelligence
Private Equity Intelligence
Firms, funds, people, portfolio companies and transactions from sworn filings and cited announcements, kept as a graph with a date and a source on every edge. Reported gross assets are never fund size, regulatory AUM is never dry powder, and a deal value prints only when someone disclosed it.
The names on this page are hidden. Create a free account and they fill in. No card, and every figure, date and source on this page is public either way.
Firms / L•••••• C•••••• P•••••••
L•••••• C•••••• P•••••••
We are an independent, international, investment fund focused on growth companies in Healthtech.
Classification
- Class
- Buyout firmprobable, confidence 65%
- Basis
- R6: 2 of 2 distinct vehicles are sworn Private Equity Funds
- Size band
- unsizeddefined by: no Private Equity Fund GAV on a filing from 2021 or later
- Strategies
- GROWTH EQUITY
Classification history (1)
- Sep 13, 2026Buyout firm (probable, 65%, cls-pe-1)R6: 2 of 2 distinct vehicles are sworn Private Equity Funds
Regulatory footprint (Form ADV)
- Adviser type
- exempt reporting adviser
- Form ADV filings
- Mar 23, 2021 to Mar 21, 2024
- RAUM
- unknownregulatory assets under management of the adviser; not dry powder, not a fund size
- PE funds, latest filing
- 2
- PE fund GAV, latest filing
- unknownreported gross assets (Form ADV), not fund size
- All private fund GAV
- unknownevery private fund type, latest filing
- 2024 PE fund GAV
- $0sum over funds typed Private Equity Fund with a 2024 or later as-of date
- PE share of funds, lifetime
- 100%
- Fund type mix
- filed 2024-03-21, latest gav Private Equity Fund 0, latest counts Private Equity Fund 2, lifetime distinct Private Equity Fund 2
- Employees
- unknown
- Headquarters
- Paris, France
- Office address
- 41 AVENUE DE FRIEDLAND, Paris, 75008
- Business phone
- +33 (0) 1 88 40 58 05
Stated criteria beside observed behaviour
19 observed deals
Stated by the firm
- Sectors
- not stated or not yet read
- Geography
- Europe, Global
- Revenue
- not stated or not yet read
- EBITDA
- not stated or not yet read
- Enterprise value
- not stated or not yet read
- Equity check
- not stated or not yet read
- Control
- not stated or not yet read
- Thesis
- L•••••• C•••••• P••••••• Invests in Bridge To Life to Back the Next Chapter in Organ Preservation
Observed from deals on record
- roles
- unknown 16, platform 3
- period
- to 2026-08-12, from 2022-06-16, undated holdings 16, dated observations 6
- window
- last 2026-08-12, first 2022-06-16
- control
- control 3, unknown 16
- companies
- 19
- geography
- count 1, share 0.053, value IL
- investments
- 19
- seller kinds
- transactions
- 3
- cadence by year
- 2022 other deals 1, 2024 platforms 1, 2026 platforms 1
- platform add on
- add ons 0, platforms 3, add ons per platform 0
- sector known for
- 6
- disclosed value usd
- n 0
- sector distribution
- count 3, share 0.158, value software, examples Synovo Group, Bridge, Matrix Requirements, count 2, share 0.105, value life sciences, examples Bridge to Life Ltd, Acandis, count 1, share 0.053, value healthcare it, examples Ospi
- holding period years
- n 0
- repeat counterparties
- subsector distribution
- count 3, share 0.158, value software, examples Synovo Group, Bridge, Matrix Requirements, count 2, share 0.105, value medical devices, examples Bridge to Life Ltd, Acandis, count 1, share 0.053, value healthcare it, examples Ospi
19 companies on the graph (3 transactions); most in software (3); 3 platforms and 0 add-ons; observed 2022 to 2026
Funds
3 on record
| Fund | Vehicle | Vintage | Reported gross assets (Form ADV), not fund size | GAV by year | Form D sold | Lifecycle |
|---|---|---|---|---|---|---|
| F••• L•••••• G••••• C•••••••• I• S••••• ADV: Private Equity Fund | Co-investment vehicle | 2024 first reported on Form ADV | $0 as of Mar 21, 2024 | no Form D | Unknown | |
| L•••••• G••••• I• S••••• ADV: Private Equity Fund | Growth fund | unknown | $0 as of Mar 21, 2024 | no Form D | Unknown | |
| L•••••• F••• I• | buyout or unlabelled | unknown | unknown | no reporting | no Form D | Unknown |
Team
18 current, 0 former
Managing partner (9)
- A••• S•••• · Co-founding Partner – San Francisco · start date unknown Investment organization websites (team, portfolio, strategy, criteria, news)
- L•••• A•••••••• S•••• · Chief Investment Officer And Deputy Ceo · since Jan 1, 2020 SEC Form ADV filing data 2011 to 2024 (Schedule D 7.B.(1) private funds, Schedules A/B, 1.I websites)
- P••••• M••••••• · Chairman And President · since Jan 1, 2020 SEC Form ADV filing data 2011 to 2024 (Schedule D 7.B.(1) private funds, Schedules A/B, 1.I websites)
- P••••• M••••••• · Co-founding Partner – Paris · start date unknown Investment organization websites (team, portfolio, strategy, criteria, news)
- P••••• M••••••• · Co-Founding Partner · start date unknown Press release wires (PR Newswire, GlobeNewswire, Business Wire public pages and RSS)
- S••••• L••• · Ceo · since Jan 1, 2020 SEC Form ADV filing data 2011 to 2024 (Schedule D 7.B.(1) private funds, Schedules A/B, 1.I websites)
- S••••• L••• · Co-founding Partner – Paris · start date unknown Investment organization websites (team, portfolio, strategy, criteria, news)
- S••••• L••• · Founding Partner · start date unknown Press release wires (PR Newswire, GlobeNewswire, Business Wire public pages and RSS)
- V••••• D•••••• · Managing Partner – Paris · start date unknown Investment organization websites (team, portfolio, strategy, criteria, news)
Partner (4)
- A••••••••• M•••••• · Investment Manager – Paris · start date unknown Investment organization websites (team, portfolio, strategy, criteria, news)
- C•••••• J••••••••• L••• · Manager · since Nov 1, 2021 SEC Form ADV filing data 2011 to 2024 (Schedule D 7.B.(1) private funds, Schedules A/B, 1.I websites)
- E•••••• F••••••• · Partner – Paris · start date unknown Investment organization websites (team, portfolio, strategy, criteria, news)
- V••••••• R••••• · Investment Manager – Paris · start date unknown Investment organization websites (team, portfolio, strategy, criteria, news)
Principal (1)
- P•••••• R••••• · Principal – Paris · start date unknown Investment organization websites (team, portfolio, strategy, criteria, news)
Operating partner (1)
- A••• Y••• · CFO & Head of Operations – Paris · start date unknown Investment organization websites (team, portfolio, strategy, criteria, news)
Investor relations (1)
- L••• d• C•••••••• · Head of Investor Relations & ESG – Paris · start date unknown Investment organization websites (team, portfolio, strategy, criteria, news)
Platform (2)
- D••••••• L•••• · Office Manager – Paris · start date unknown Investment organization websites (team, portfolio, strategy, criteria, news)
- P•••••• B••••• · Compliance Officer – Paris · start date unknown Investment organization websites (team, portfolio, strategy, criteria, news)
Portfolio
19 relationships, 3 platforms, 0 add-ons
Transactions
4 on record
| Date | Type | Target | This firm’s role | Source |
|---|---|---|---|---|
| Aug 12, 2026 | Platform acquisition | B••••• | Sponsor (confirmed) | l••••••.com |
| Aug 25, 2025 | Exit to a strategic buyer | O•••••• | Seller (confirmed) | l••••••.com |
| Nov 25, 2024 | Platform acquisition | G•••• D••• | Sponsor (confirmed) | l••••••.com |
| Jun 16, 2022 | Majority investment | M••••• R••••••••• | Sponsor (confirmed) | l••••••.com |
Placement agents, lenders, advisers and co-investors
15 relationships
Placement agents (8)
- M••••••••• F••••• O••••• 1 shared · one time · last Jan 1, 2021
- M••• N•••• 1 shared · one time · last Jan 1, 2021
- B•••••• C•••••••• 1 shared · one time · last Jan 1, 2021
- B•••••• L•••••• 1 shared · one time · last Jan 1, 2021
- F••••••• L•••••• 1 shared · one time · last Jan 1, 2021
- J••••••••• M•••••• 1 shared · one time · last Jan 1, 2021
- N•••••• G••••• 1 shared · one time · last Jan 1, 2021
- J••• A••••••• 1 shared · one time · last Jan 1, 2021
Lenders (1)
- S••••• C•••••• C••••• O••••••••• F••• 1 shared · one time · last Aug 12, 2026
Financial advisers (5)
- U•• I••••••••• B••• 1 shared · one time · last Aug 12, 2026
- G•••••• L••••••••• 1 shared · one time · last Jun 16, 2022
- G•••••• P•••••• 1 shared · one time · last Nov 25, 2024
- T••••• L•• 1 shared · one time · last Jun 16, 2022
- F•••• G•••• S••••••••• 1 shared · one time · last Jun 16, 2022
Legal advisers (1)
- L•••• • B•••••• L•• 1 shared · one time · last Aug 12, 2026
LP commitments
0 disclosed
No LP commitment collected yet. An LP edge needs a public disclosure with a quote, such as a pension plan’s report or an announcement naming the LP.
Events
29 most recent
- Aug 12, 2026L•••••• C•••••• P••••••• Invests in B••••• To L••• to Back the Next Chapter in Organ PreservationPlatform investmentFactB•••••Press release wires (PR Newswire, GlobeNewswire, Business Wire public pages and RSS)
- Aug 12, 2026L•••••• C•••••• P••••••• Invests in B••••• To L••• to Back the Next Chapter in Organ Preservation
- Jul 30, 2026L•••••• C•••••• P••••••• Invests in G••••••••• to Drive Global Diagnostics Expansion
- May 19, 2026L•••••• C•••••• P••••••• closes fund ll, at €520m – vcwire.tech
- May 19, 2026L•••••• C•••••• P••••••• Raises €520 million Fund II to Scale a New Generation of European Healthtech Leaders – Press release
- May 19, 2026L•••••• C•••••• P••••••• closes fund ll, at €520m – vcwire.tech
- May 19, 2026L•••••• Capital closes €520M fundraising to propel European medtech – Mugglehead
- May 19, 2026L•••••• Closes €520M Fund as European Healthtech Investors Push for U.S. Scale – Europe Says
- May 19, 2026L•••••• closed a €520m healthtech fund in under 18 months. Here is how it did it – TFN
- Jan 7, 2026L•••••• C•••••• P••••••• supports M••••• O••’s strategic expansion with two acquisitions, strengthening its life sciences software platform
- Nov 18, 2025L•••••• C•••••• P••••••• appoints Dr. Oern Stuge as Senior Advisor – Press release
- Aug 25, 2025Terumo to acquire Organox Limited for approximately USD $1.5 billion
- Aug 25, 2025Terumo to acquire Organox Limited for approximately USD $1.5 billion
- Aug 25, 2025Terumo to acquire O•••••• Limited, a leading innovator in organ preservation devices, marking strategic entry into the organ transplantation-related sector
- Aug 25, 2025Oxford university spinout O•••••• sold to Japanese group Terumo for $1.5bn
- Jul 15, 2025L•••••• C•••••• P••••••• is proud to announce its investment in A••••••, a leading Swedish Imaging Drug Development Partner
- Feb 24, 2025L•••••• C•••••• P••••••• Co-Leads a $142m Equity Investment Into O••••••
- Jan 22, 2025L•••••• Invests €50m in A••••••, a German, Neurovascular M•••••• Device Company Dedicated to the Prevention and Treatment of Stroke
- Nov 25, 2024L•••••• C•••••• P••••••• Acquires G•••• D•••
- Nov 25, 2024L•••••• C•••••• P••••••• Acquires G•••• D•••
- May 29, 2024N•••••• C••••• Closes $55m Series C Financing Round Led by L•••••• C•••••• P•••••••
- Mar 4, 2024L••••••’s charitable partnership with Institut Imagine is explained in this interview with Stanislas Lyonnet and P••••• M•••••••
- Oct 10, 2023L•••••• C•••••• P••••••• signs a partnership with Institut Imagine to fund groundbreaking research into rare diseases
- Sep 26, 2023Creation of O•••, the result of the merger between Groupe PSIH and Collective Thinking
- Sep 12, 2023L•••••• C•••••• P••••••• invests €17 million in Swedish regenerative medicine leader B•••••••• AB
- Jul 17, 2023L•••••• C•••••• P••••••• has led a £25m growth investment into O••••••
- Jun 16, 2022L•••••• C•••••• P••••••• invests €10m in German Medtech software company M••••• R•••••••••
- Jun 16, 2022L•••••• C•••••• P••••••• invests €10m in German Medtech software company M••••• R•••••••••
- Mar 23, 2021L•••••• C•••••• P••••••• first filed Form ADV in the extract (ERA)
Across the graphs
L•••••• C•••••• P••••••• is the same institution as 1 record in RIA and Wealth.
RIA and Wealth1
Which record it is in each graph, what it is called there, and what the two were joined on. The Data Factory holds all nine graphs and the identity layer between them.
Checking your plan…